🇺🇸 FDA
Patent

US 11576951

Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

granted A61KA61K38/26A61K45/06

Quick answer

US patent 11576951 (Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same) held by XERIS PHARMACEUTICALS, INC. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/26, A61K45/06, A61K47/02, A61K47/10